AKT1 and cancer: For instance, ROS can activate survival signaling pathways in cancer cells, including the MAPK/ERK1/2, phosphoinositide-3-kinase/protein kinase B (PI3K/Akt), p38, and c-Jun N-terminal kinase (JNK) pathways.